Canada - English - Health Canada

apotex inc - clomipramine hydrochloride - tablet - 25mg - clomipramine hydrochloride 25mg - tricyclics and other norepinephrine-reuptake inhibitors

Canada - English - Health Canada

apotex inc - clomipramine hydrochloride - tablet - 10mg - clomipramine hydrochloride 10mg - tricyclics and other norepinephrine-reuptake inhibitors

Canada - English - Health Canada

apotex inc - clomipramine hydrochloride - tablet - 50mg - clomipramine hydrochloride 50mg - tricyclics and other norepinephrine-reuptake inhibitors

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - clomipramine hydrochloride - oral capsule - 50mg

European Union - English - EMA (European Medicines Agency)

virbac s.a. - clomipramine hydrochloride - psychoanaleptics - dogs - as an aid in the treatment of separation related disorders in dogs manifested by destruction and inappropriate elimination (defecation and urination) and only in combination with behavioural modification techniques.

Israel - English - Ministry of Health

tzamal bio-pharma ltd - clomipramine hydrochloride - tablets slow release - clomipramine hydrochloride 75 mg - clomipramine - clomipramine - depression of varying origin: in children and adolescents there is not sufficient evidence of safety and efficacy of anafranil in the treatment of depressive states of varying aetiology and symptomatology. the use of anafranil in children and odolescents ( 0 - 17 years of age ) in this indication is therefore not recommended. obsessive compulcive syndromes: no experience is available in children younger than 5 years of age.

Israel - English - Ministry of Health

unipharm ltd, israel - clomipramine hydrochloride - tablets slow release - clomipramine hydrochloride 75 mg - clomipramine - clomipramine - treatment of depressive states. obsessive compulsive disorders.

Israel - English - Ministry of Health

tzamal bio-pharma ltd - clomipramine hydrochloride - coated tablets - clomipramine hydrochloride 25 mg - clomipramine - clomipramine - depression of varying origin: in children and adolescents there is not sufficient evidence of safety and efficacy of anafranil in the treatment of depressive states of varying aetiology and symptomatology. the use of anafranil in children and odolescents ( 0 - 17 years of age ) in this indication is therefore not recommended. obsessive compulcive syndromes: no experience is available in children younger than 5 years of age.

Ireland - English - HPRA (Health Products Regulatory Authority)

novartis pharmaceuticals uk ltd - clomipramine hydrochloride - tablets - 75 milligram - non-selective monoamine reuptake inhibitors

Singapore - English - HSA (Health Sciences Authority)

duopharma (singapore) pte ltd - clomipramine hcl - tablet - 25 mg - clomipramine hcl 25 mg